Literature DB >> 17477424

Long-term effect of FTY720 on lymphocyte count and islet allograft survival in mice.

Longshan Liu1, Changxi Wang, Xiaoshun He, Wenjun Shang, Ying Bi, Dong Wang.   

Abstract

This study was performed to observe the long-term effect of FTY720 on lymphocyte count change and islet allograft survival. Diabetic C57BL/6 mice were given FTY720 (group 1, 0.5 mg/kg/day; group 2, 1.0 mg/kg/day) or its vehicle (group 3, controls) after transplantation. Median graft survival time was prolonged in a dose-dependent manner (group 1, 84.5 days; group 2, >100 days, and group 3, 10 days, P < 0.01). Peripheral blood lymphocytes in groups 1 and 2 decreased to 23.81% and 12.59% compared with control group after FTY720 treatment. Lymphocytes from mesenteric lymph nodes and axillary nodes in groups 1 and 2 significantly increased on day 5, but decreased on day 14. Lymphocyte infiltration to the graft site was attenuated in groups 1 and 2. In conclusion, continuous FTY720 administration can induce and maintain lymphopenia, and inhibit lymphocytes from infiltrating the graft site so as to prolong islet allograft survival in mice. Copyright (c) 2007 Wiley-Liss, Inc. Microsurgery 2007.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17477424     DOI: 10.1002/micr.20360

Source DB:  PubMed          Journal:  Microsurgery        ISSN: 0738-1085            Impact factor:   2.425


  8 in total

1.  Effect of a new drug releasing system on microencapsulated islet transplantation.

Authors:  Binjie Lu; Qingkun Gao; Rui Liu; Ming Ren; Yan Wu; Zaixing Jiang; Yi Zhou
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

2.  Effects of Immunomodulatory Drug Fingolimod (FTY720) on Chlamydia Dissemination and Pathogenesis.

Authors:  Zengzi Zhou; Lingxiang Xie; Luying Wang; Min Xue; Dabao Xu; Guangming Zhong
Journal:  Infect Immun       Date:  2020-10-19       Impact factor: 3.441

Review 3.  Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism.

Authors:  William L Holland; Scott A Summers
Journal:  Endocr Rev       Date:  2008-05-01       Impact factor: 19.871

Review 4.  New extracellular factors in glioblastoma multiforme development: neurotensin, growth differentiation factor-15, sphingosine-1-phosphate and cytomegalovirus infection.

Authors:  Jan Korbecki; Izabela Gutowska; Ireneusz Kojder; Dariusz Jeżewski; Marta Goschorska; Agnieszka Łukomska; Anna Lubkowska; Dariusz Chlubek; Irena Baranowska-Bosiacka
Journal:  Oncotarget       Date:  2018-01-09

Review 5.  To Be or Not to Be: The Divergent Action and Metabolism of Sphingosine-1 Phosphate in Pancreatic Beta-Cells in Response to Cytokines and Fatty Acids.

Authors:  Ewa Gurgul-Convey
Journal:  Int J Mol Sci       Date:  2022-01-31       Impact factor: 5.923

6.  FTY720 protects cardiac microvessels of diabetes: a critical role of S1P1/3 in diabetic heart disease.

Authors:  Zhiyong Yin; Linni Fan; Liping Wei; Haokao Gao; Rongqing Zhang; Ling Tao; Feng Cao; Haichang Wang
Journal:  PLoS One       Date:  2012-08-14       Impact factor: 3.240

Review 7.  Roles of ceramide and sphingolipids in pancreatic β-cell function and dysfunction.

Authors:  Ebru Boslem; Peter J Meikle; Trevor J Biden
Journal:  Islets       Date:  2012 May-Jun       Impact factor: 2.694

Review 8.  Sphingolipids in Type 1 Diabetes: Focus on Beta-Cells.

Authors:  Ewa Gurgul-Convey
Journal:  Cells       Date:  2020-08-04       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.